Spectromics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $1.25M
Latest Deal Amount
  • Investors
  • 3

Spectromics General Information

Description

Developer of a diagnostic technology designed to assist in the fight against growing levels of microbial resistance to antibiotics. The company's technology offers simple, accurate and cost-effective point-of-prescription tests for bacterial infections that identifies anti-microbial susceptibility and resistance during a patient appointment as well as provides guidance on the effective treatment for a particular pathogen and which drug to prescribe, enabling healthcare professionals eliminating ineffective empirical prescriptions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • 46 Grafton Street
  • Manchester M13 9NT
  • England, United Kingdom
+44 01580 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Spectromics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 29-Jun-2015 $1.25M 00.000 Completed Startup
To view Spectromics’s complete valuation and funding history, request access »

Spectromics Executive Team (3)

Name Title Board Seat Contact Info
Neil Butler Chief Executive Officer & Board Member
Matthew Upton Co-Founder & Board Member
Royston Goodacre Ph.D Co-Founder & Board Member
To view Spectromics’s complete executive team members history, request access »

Spectromics Board Members (4)

Name Representing Role Since
Ian George Ph.D Self Board Member 000 0000
Matthew Upton Spectromics Co-Founder & Board Member 000 0000
Neil Butler Spectromics Chief Executive Officer & Board Member 000 0000
Royston Goodacre Ph.D Spectromics Co-Founder & Board Member 000 0000
To view Spectromics’s complete board members history, request access »

Spectromics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Douglas Kell Angel (individual) Minority 000 0000 000000 0
MTI Partners Venture Capital Minority 000 0000 000000 0
New Wave Ventures Venture Capital Minority 000 0000 000000 0
To view Spectromics’s complete investors history, request access »